The Ocular Ketorolac market involves pharmaceutical products containing ketorolac tromethamine, a potent non-steroidal anti-inflammatory drug (NSAID) delivered via eye drops. Its primary utility is the management of ocular pain and inflammation, most critically following high-volume procedures like cataract surgery, and also for treating seasonal allergic conjunctivitis. The market is... https://www.databridgemarketresearch.com/